Table 2 Clinical manifestations of patients with myocarditis
From: Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
Clinical manifestation | Patients (n), No. (%) |
|---|---|
Accompanied by symptoms | Â |
 No | 36(54.5) |
 Yes | 30(45.5) |
Electrocardiogram change | Â |
 No | 25(37.) |
 Yes | 41(62.1) |
Elevated biomarkers | Â |
 Only CK-MB | 10(15.2) |
 Only hs-cTnI | 10(15.2) |
 Both | 45(68.1) |
Other elevated biomarkers | Â |
 TC | 45 (68.2) |
 TG | 44 (66.7) |
 NLR | 21 (31.8) |
Types of myocarditis | Â |
 Definite myocarditis | 1(1.5) |
 Probable myocarditis | 5(7.6) |
 Possible myocarditis | 60(90.9) |
Grade of myocarditis | Â |
 G1 | 57(86.4) |
 G2 | 5(7.6) |
 G3 | 2(3.0) |
 G4 | 2(3.0) |
Echocardiography changes | Â |
 No | 57(86.4) |
 Left ventricular diastolic hypoplasia | 7(10.) |
 Ventricular wall segmental motion abnormalities | 2(3.0) |
cMRI change | Â |
 No | 65(98.5) |
 Oedema and delayed enhancement | 1 (1.5) |
Concurrent other irAEs | Â |
 No | 36(54.5) |
 Thyroiditis | 8(12.1) |
 Pneumonia | 7(10.6) |
 Liver dysfunction | 7(10.6) |
 Rash | 6(9.1) |
 Myositis | 3(4.5) |
 Renal injury | 3(4.5) |
 Heart failure | 2(3.0) |
 Pancreatitis | 2(3.0) |
 Venous thromboembolism | 2(3.0) |
 Neuritis | 1(1.5) |
 Adrenal insufficiency | 1(1.5) |